Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: study protocol for a randomized controlled trial.

ABSTRACT: Background: Bipolar I disorder (BD-I) is a chronic mental illness characterized by the presence of one or more manic episodes, or both depressive and manic episodes, usually separated by asymptomatic intervals. Pharmacists can contribute to the management of BD-I, mainly with the use of ef...

Full description

Autores:

Salazar Ospina, Andrea
Amariles Muñoz, Pedro
Gutiérrez Henao, Francisco Javier
Faus Dader, María José
Benjumea Gutiérrez, Dora María
Rodríguez, Luis Fernando
Agudelo Agudelo, Juan Fernando
Bedoya Álvarez, Jorge Andrés

Tipo de recurso:

Article of investigation

Fecha de publicación:

2014

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/36867

Acceso en línea:

https://hdl.handle.net/10495/36867

Palabra clave:

Antipsicóticos - efectos adversos
Antipsychotic Agents - adverse effects
Antipsicóticos - uso terapéutico
Antipsychotic Agents - therapeutic use
Trastorno Bipolar
Bipolar Disorder
Distribución de Chi-Cuadrado
Chi-Square Distribution
Protocolos Clínicos
Clinical Protocols
Colombia
Servicios Comunitarios de Farmacia
Community Pharmacy Services
Pacientes Ambulatorios
Outpatients
Estudios Prospectivos
Prospective Studies
Escalas de Valoración Psiquiátrica
Psychiatric Status Rating Scales
Proyectos de Investigación
Research Design
Resultado del Tratamiento
Treatment Outcome
Ensayos Clínicos Controlados como Asunto
Controlled Clinical Trials as Topic

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/